Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Regitz

Showing results (21-30 of 109) with videos related to

Pageof 11
Sort By:
Der Internist|February 28, 2008
[Heart failure--are there gender aspects?]V Regitz-Zagrosek, E Lehmkuhl, H B Lehmkuhl
Klinische Wochenschrift|April 15, 1982
[Carnitine deficiency: a treatable cause of cardiomyopathy in children (author's transl)]V Regitz, R J Hodach, A L Shug
Biochemical and Biophysical Research Communications|November 15, 1994
Human cardiac fibroblasts express an angiotensin receptor with unusual binding characteristics which is coupled to cellular proliferationM Neuss, V Regitz-Zagrosek, A Hildebrandt, et al.
Cell and Tissue Research|October 1, 1996
Isolation and characterisation of human cardiac fibroblasts from explanted adult heartsM Neuss, V Regitz-Zagrosek, A Hildebrandt, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|July 1, 1995
Use of angiotensin II antagonists in human heart failure: function of the subtype 1 receptorV Regitz-Zagrosek, M Neuss, J Holzmeister, et al.
American Heart Journal|April 1, 1995
Angiotensin-converting enzyme inhibitors and beta-blockers in long-term treatment of dilated cardiomyopathyV Regitz-Zagrosek, B Leuchs, J Krülls-Münch, et al.
Herz|November 21, 2018
[Update of the ESC guidelines 2018 on cardiovascular diseases during pregnancy : Most important facts]U Seeland, J Bauersachs, J Roos-Hesselink, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|November 4, 2004
Gender aspects in heart failure. Pathophysiology and medical therapyV Regitz-Zagrosek, E Lehmkuhl, H B Lehmkuhl, et al.
Cardiovascular Research|November 1, 1981
Biochemical mechanism of infarct size reduction by pyruvateV Regitz, T Azumi, H Stephan, et al.
The American Journal of Cardiology|August 15, 1993
Effects of acute administration of cyclosporine on levels of cardiovascular hormones in heart transplant recipientsJ Sehested, S Schifter, E Schmitzer, et al.
Pageof 11

Showing results (21-30 of 109) with videos related to

Sort By:
Pageof 11
Der Internist|February 28, 2008
[Heart failure--are there gender aspects?]V Regitz-Zagrosek, E Lehmkuhl, H B Lehmkuhl
Klinische Wochenschrift|April 15, 1982
[Carnitine deficiency: a treatable cause of cardiomyopathy in children (author's transl)]V Regitz, R J Hodach, A L Shug
Biochemical and Biophysical Research Communications|November 15, 1994
Human cardiac fibroblasts express an angiotensin receptor with unusual binding characteristics which is coupled to cellular proliferationM Neuss, V Regitz-Zagrosek, A Hildebrandt, et al.
Cell and Tissue Research|October 1, 1996
Isolation and characterisation of human cardiac fibroblasts from explanted adult heartsM Neuss, V Regitz-Zagrosek, A Hildebrandt, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|July 1, 1995
Use of angiotensin II antagonists in human heart failure: function of the subtype 1 receptorV Regitz-Zagrosek, M Neuss, J Holzmeister, et al.
American Heart Journal|April 1, 1995
Angiotensin-converting enzyme inhibitors and beta-blockers in long-term treatment of dilated cardiomyopathyV Regitz-Zagrosek, B Leuchs, J Krülls-Münch, et al.
Herz|November 21, 2018
[Update of the ESC guidelines 2018 on cardiovascular diseases during pregnancy : Most important facts]U Seeland, J Bauersachs, J Roos-Hesselink, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|November 4, 2004
Gender aspects in heart failure. Pathophysiology and medical therapyV Regitz-Zagrosek, E Lehmkuhl, H B Lehmkuhl, et al.
Cardiovascular Research|November 1, 1981
Biochemical mechanism of infarct size reduction by pyruvateV Regitz, T Azumi, H Stephan, et al.
The American Journal of Cardiology|August 15, 1993
Effects of acute administration of cyclosporine on levels of cardiovascular hormones in heart transplant recipientsJ Sehested, S Schifter, E Schmitzer, et al.
Pageof 11